Twist Bioscience Corp

CRISPR Therapeutics

Recursion Pharmaceuticals

Veracyte

Natera

CareDx

Adaptive Biotechnologies

Guardant Health Inc

Beam Therapeutics

Schrodinger 

ARK Genomic Revolution Multi-Sector ETF

ARKG is an actively managed fund that targets companies involved in the genomics industry.

ARK Fintech Innovation ETF

ARK Innovation ETF

ARK Industrial Innovation ETF

ARK Web x.0 ETF

ARK Space Exploration & Innovation ETF

The broad markets slid again on Tuesday but most of this action came right before the close, however, the family of ARK Invest ETFs were mostly positive.

Cathie Wood's ARK Invest Buys for 5/18

Cancer remains one of the leading causes of death around the world, but advancements in genomics are enhancing detection and screening capabilities. For investors, that puts the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) at the forefront of vital healthcare developments.

How Genomics Is Improving Cancer Screening, Investing

The words impact investing typically bring to mind strategies that allocate funds to reflect strong environmental principles. What they often miss is the intersection of disruptive technology with sustainable investing principles.

Is This Ark Invest ETF a Sustainable Investing Play?

"What worked in 2020 hasn't been working in 2021 and that's not gonna change, so get used to it," Jim Cramer said on "Mad Money."

Dubbed 'WoodStocks,' Jim Cramer sees Cathie Wood's top tech picks heading lower

The market was not favorable for ARK investors on Monday with all of the ETFs taking a loss on the day.

Cathie Wood's ARK Invests Buys For 5/10

Twist Bioscience brings to mind another genomic revolution pioneer.

Why Does Cathie Wood Like This Healthcare Stock So Much?

Within the fast-growing genomics universe, one of the more compelling themes is the evolution of gene therapies – a theme the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is levered to. Relative to passive genomics exchange traded funds, the actively managed ARKG can more rapidly adjust gene therapy exposure.

Accelerating Gene Therapies? There's an ETF for That

ARKG's Sharpe Ratio and outperformance suggest great stock-picking by the fund manager. However, the neutral rating is premised on a long-term time horizon for value realization in view of ARKG's rich valuation.

ARK Genomic Revolution ETF: Value Realization Will Take Time

Amplify Treatments Testing & Advancements ETF

iShares Nasdaq Biotechnology ETF

iShares U.S. Healthcare Providers ETF

Invesco S&P 500 Equal Weight Health Care ETF

ALPS Medical Breakthroughs ETF

Health Care Select Sector SPDR Fund

The healthcare sector outperformed in the past year due to the pandemic. Here are seven ETFs for your portfolio to look beyond Covid-19.

7 Health-Focused ETFs To Buy Now For the Post-Covid Future

Amplify Online Retail ETF

Renaissance IPO ETF

Global X Lithium & Battery Tech ETF

Roundhill Esports & Digital Entertainment ETF

Invesco WilderHill Clean Energy ETF

Invesco Dynamic Semiconductors ETF

Invesco DWA Technology Momentum ETF

SPDR S&P Retail ETF

President Joe Biden wants to raise capital gains tax to 39.6% from the current rate of 20% for those earning $1 million or more. Since the group is just 0.3% of total population, don't expect a severe market crash over the long term.

Likely Capital Gain Tax Hike a Buying Point for These ETFs?

Genomics is a fast-growing, rapidly evolving industry and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is a prime example of an exchange traded fund that's nimble enough to capture that evolution. ARKG includes companies that merge healthcare with technology to capitalize on the revolution in genomic sequencing.

Long Read Sequencing Is Securing a Long Runway for ‘ARKG'

These ETFs have experienced staggering returns. But are they right for you?

Should You Invest in ARK ETFs Right Now?

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is a prime example of an exchange traded fund with lots of levers to pull. Since it's an actively managed fund, it's worth examining some of the stocks that could propel ARKG higher this year.

A Dynamic Duo that Could Power ‘ARKG' Higher

Wood has big bets on names like Square and PayPal, which dominate the digital wallet space.

Cathie Wood sees these 2 trends as the next big things after electric vehicles

Early cancer detection is an emerging frontier for healthcare companies. The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is among the exchange traded funds best positioned to capitalize on that trend.

Cancer Detection Meets Portfolio Perfection: The ARKG ETF

The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is obviously positioned as a genomics fund, but as an actively managed exchange traded fund, it can venture into other growth areas in the healthcare sector. That includes telemedicine, as highlighted by the fund's significant exposure to Teledoc (NYSE: TDOC).

The ARKG ETF: Genomics Exposure with a Twist

Cathie Wood-led Ark Investment Management on Friday bought in more shares of the blank-check company Jaws Spitfire Acquisition Corp (NYSE: SPFR), its third such purchase for its newest fund Ark Space Exploration & Innovation (NYSE: ARKX). The Barry Sternlicht- and Serena Williams-backed Jaws Spitfire is reported to be in talks to take SpaceX's 3D printer supplier Velo3D public in a SPAC deal, which could value the company $1 billion.

Docusign, LendingTree, And Velo3D's Rumored SPAC — What Cathie Wood's Ark Bought And Sold Today

Baidu

General Motors

Block

Teradyne

Tesla

Value investors who want to supercharge their portfolios with disruptive growth technologies can steal ideas from Cathie Wood's Ark Invest. Baidu and Teradyne are two of the most promising ARKK holdings with a trifecta of lucrative growth potential, reasonable valuation, and stable history of profits.

Poaching From Ark Invest: Innovative Disruption For Value Investors

ARK Invest has been the talk of Wall Street over the last couple of years, outperforming the market and solidifying its place among the big players in the investments world.

Cathie Wood's ARK Invest Buys and Sells 4/8

Cathie Wood's ARK Invest Buys and Sells 4/7

Cathie Wood's ARK Invest Buys and Sells 4/6

Cathie Wood's ARK Invest Buys and Sells 4/5

I am a big fan of the ARK funds and Cathie Wood in particular. Upon reviewing the asset mix of the ARK Genomic Revolution Multi-Sector ETF, I came away less than enthused.

News for ARK Genomic Revolution Multi-Sector ETF ETF (ARKG)